Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Improving sleep in children with autism and insomnia

Official title: Targeting Insomnia in School Aged Children With Autism Spectrum Disorder

Run by University of Missouri-Columbia · NCT04545606 · Data updated 2026-11-12

This study is testing a new sleep therapy for children with autism and insomnia to see if it can help them sleep better and feel more awake during the day.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment180 (estimated)
SponsorUniversity of Missouri-Columbia
Academic / other
Locations1 site (Columbia, Missouri)
StatusRecruiting
StartedSeptember 15, 2020
Main results expectedAugust 2025
Study endsAugust 2030
Registry record updatedMarch 15, 2024
Trial IDNCT04545606 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6-12 years with a diagnosis of Autism Spectrum Disorder and insomnia, along with their parent or guardian.

Probably not a fit

Patients who do not have a diagnosis of ASD or insomnia, or those unable to participate due to language barriers or lack of parental consent, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to help children with Autism Spectrum Disorder (ASD) who also suffer from insomnia by providing behavioral therapy focused on improving sleep. Participants will undergo four sessions of therapy, followed by four booster sessions, with families randomly assigned to either in-person or remote therapy options. The study will measure sleep quality and related behaviors over time, assessing the effectiveness of these interventions in both improving sleep and reducing daytime dysfunction. The inclusion of remote therapy options aims to increase accessibility for families, particularly those in underserved areas.

Why it matters

Potential benefit: If successful, this study could significantly improve sleep quality for children with autism, leading to better daytime behavior and overall family well-being.

How similar studies have gone: Previous studies have shown promise in using behavioral therapies for sleep issues in children, but this specific approach for children with autism is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\) 6-12a yrs
* 2\) Verbal IQ \>= 70
* 3\) participation of child's parent or legal guardian living in the same home
* 4\) parent/guardian ability to read and understand English at the 5th-grade level
* 5\) child diagnosed with ASD and insomnia

ASD:

* 1\) previous DSM diagnosis of ASD
* 2\) evaluation using gold-standard diagnostic tools (i.e., Autism Diagnostic Observation Schedule (ADOS) and/or Autism Diagnostic Interview-Revised \[ADI-R\])

Insomnia:

* 1\) complaints of difficulties falling asleep, staying asleep, or early morning awakening by child report or parent observation for 3+ mos
* 2\) daytime dysfunction (mood, cognitive, social, academic) due to insomnia
* 3\) baseline diaries and actigraphy indicate \>30 mins. of sleep onset latency, wake after sleep onset, or early morning awakening (time between last awakening and out of bed time) on 6+ nights

Exclusion Criteria:

* 1\) parent unable to provide informed consent or child unable to provide assent
* 2\) unwilling to accept random assignment
* 3\) participation in another randomized research project
* 4\) parent unable to complete forms or implement treatment procedures due to cognitive impairment
* 5\) untreated medical comorbidity, including other sleep disorders (e.g., apnea, epilepsy, psychotic disorders, suicidal ideation/intent, \[frequent\] parasomnias)
* 6\) psychotropic or other medications that alter sleep with the exceptions of stimulants, sleep medications, and/or melatonin as described in #7 (see Notes below for details)
* 7\) stimulants, sleep medications (prescribed or OTC), and/or melatonin within the last 1 month (unless stabilized on medication for 3+ months)
* 8\) participation in non-pharmacological treatment (including CBT) for sleep outside current trial
* 9\) parent report of inability to undergo Holter Monitoring or actigraphy (e.g., extreme sensitivity, behavioral outbursts)
* 10\) other conditions adversely affecting trial participation

Where it's running

  • Thompson Center for Autism and Neurodevelopmental Disorders
    Columbia, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.